• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2022.17024

Features of pericardial lesion in pregnant women

[Lecture. Clinical decisions support]
Natalia Yurievna Shimokhina; Marina Mikhailovna Petrova; Pavel Anatolyevich Sherstny;

According to the European Society of Cardiology, almost 40 % of healthy pregnant women have a small or moderate amount of effusion in the pericardial cavity. Among all lesions of the pericardium, during pregnancy, the most common asymptomatic hydropericardium occurs. Cardiac tamponade is rare in pregnant women. In most cases, a specific etiology of pericardial effusion is not detected, however, differential diagnosis includes a wide range of diseases, often being a serious interdisciplinary task. The full use of diagnostic capabilities in pregnant women is limited by the danger of harmful effects on the fetus, and therefore echocardiography is the leading method of visualization. Particular attention in the differential diagnosis of pericardial damage in pregnant patients is given to pulmonary thromboembolism, as one of the main causes of maternal mortality. Available data on the treatment of pericarditis in women during pregnancy and lactation are extremely limited. First-line drugs are non-steroidal anti-inflammatory drugs and glucocorticoids, the administration of
immunosuppressive, antibacterial therapy is regulated in special clinical cases.

Download

References:
1. Kumar N., Pandey A., Jain P., Garg N. Acute Pericarditis-Associated Hospitalization in the USA: A Nationwide Analysis, 2003-2012. Cardiology. 2016;135(1):27-35; 2018;211(1):14-24. https://doi.org/10.1159/000445206
2. Kytö V., Sipilä J., Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014;130(18):1601-1606. https://doi.org/10.1161/CIRCULATIONAHA.114.010376
3. Adler Y., Charron P., Imazio M., Badano L., Barón-Esquivias G. [et al.]. ESC Scientific Document Group. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart. J. 2015;36(42):2921-2964. https://doi.org/10.1093/eurheartj/ehv318
4. Azarbal A., Le Winter M. M. Pericardial Effusion. Cardiol. Clin. 2017;35(4):515-524. https://doi.org/10.1016/j.ccl.2017.07.005
5. Brucato A., Pluymaekers N., Tombetti E., Rampello S., Maestroni S. [et al.]. Management of idiopathic recurrent pericarditis during pregnancy. Int. J. Cardiol. 2019;282:60-65. https://doi.org/10.1016/j.ijcard.2019.02.003
6. Heinlen L., Chakravarty E. F. Reproductive Health Screening in Women with Autoimmune Diseases. Rheum. Dis. Clin. North. Am. 2017;43(2):161-171. https://doi.org/10.1016/j.rdc.2016.12.010
7. Lazaros G., Imazio M., Brucato A., Tousoulis D. Untying the Gordian knot of pericardial diseases: A pragmatic approach. Hellenic J. Cardiol. 2016;57(5):315-322. https://doi.org/10.1016/j.hjc.2016.11.024
8. Fardman A., Charron P., Imazio M., Adler Y. European Guidelines on Pericardial Diseases: a Focused Review of Novel Aspects. Curr. Cardiol. Rep. 2016;18(5):46. https://doi.org/10.1007/s11886-016-0721-1
9. Mager A., Hammer Y., Ofek H., Kedmi I., Iakobishvili Z., Kornowski R. Prognostic and Diagnostic Significance of Serum High-Sensitivity C-Reactive Protein Level in Patients with Acute Idiopathic Pericarditis. Isr. Med. Assoc. J. 2019;21(11):747-751.
10. Blank N., Lorenz H. M. Idiopathic Pericarditis-an Autoinflammatory Disease? Curr. Rheumatol. Rep. 2019;21(5):18. https://doi.org/10.1007/s11926-019-0820-2
11. Imazio M., Gaita F. Acute and Recurrent Pericarditis. Cardiol. Clin. 2017;35(4):505-513. https://doi.org/10.1016/j.ccl.2017.07.004
12. Liu S., Elkayam U., Naqvi T. Z. Echocardiography in Pregnancy: Part 1. Curr. Cardiol. Rep. 2016;18(9):92. https://doi.org/10.1007/s11886-016-0760-7
13. Khashper A., Gruber J. M., Fraser R. S., Discepola F., Semionov . Review of Thoracic Imaging Findings Unique to Women. Can. Assoc. Radiol. J. 2015;66(3):223-230. https://doi.org/10.1016/j.carj.2014.11.007
14. Kaur A., Miller M. General Management Principles of the Pregnant Woman. Semin. Respir. Crit. Care. Med. 2017;38(2):123-134. https://doi.org/10.1055/s-0037-1602167
15. Tonini M., Melo D. T., Fernandes F. Acute pericarditis. Rev. Assoc. Med. Bras. (1992). 2015;61(2):184-190. https://doi.org/10.1590/1806-9282.61.02.184
16. Chiabrando J. G., Bonaventura A., Vecchié A., Wohlford G. F., Mauro A. G. [et al.]. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020;75(1):76-92. https://doi.org/10.1016/j.jacc.2019.11.021
17. Sarkar M., Bhardwaj R., Madabhavi I., Gowda S., Dogra K. Pulsus paradoxus. Clin. Respir. J. 2018;12(8):2321-2331. https://doi.org/10.1111/crj.12912
18. Righini M., Robert-Ebadi H., Le Gal G. Diagnosis of acute pulmonary embolism. J. Thromb. Haemost. 2017;15(7):1251-1261. https://doi.org/10.1111/jth.13694
19. Simcox L. E., Ormesher L., Tower C., Greer I. A. Pulmonary thrombo-embolism in pregnancy: diagnosis and management. Breathe (Sheff). 2015;11(4):282-289. https://doi.org/10.1183/20734735.008815
20. Regitz-Zagrosek V., Roos-Hesselink J. W., Bauersachs J., Blomström-Lundqvist C., Cífková R. [et al.]. ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur. Heart. J. 2018;39(34):3165-3241. https://doi.org/10.1093/eurheartj/ehy340
21. Vakamudi S., Ho N., Cremer P. C. Pericardial Effusions: Causes, Diagnosis, and Management. Prog. Cardiovasc. Dis. 2017;59(4):380-388. https://doi.org/10.1016/j.pcad.2016.12.009
22. Celentani D., Di Cuia M., Imazio M., Gaita F. Recent advances in the management of pericardial diseases. Hosp. Pract. (1995). 2016;44(5):266-273. https://doi.org/10.1080/21548331.2016.1265416
23. Romagano M. P., Patel K., Williams S., Apuzzio J. J. Evaluation and Treatment of Cardiac Tamponade in a Pregnant Patient. Case. Rep. Obstet. Gynecol. 2020;2020:8703980. https://doi.org/10.1155/2020/8703980
24. Götestam Skorpen C., Hoeltzenbein M., Tincani A., Fischer- Betz R., Elefant E. [et al.]. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann. Rheum. Dis. 2016;75(5):795-810. https://doi.org/10.1136/annrheumdis-2015-208840
25. Bala M. M., Paszek E., Lesniak W., Wloch-Kopec D., Jasinska K., Undas A. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies. Cochrane Datab. Syst. Rev. 2018;7(7):CD012534. https://doi.org/10.1002/14651858.CD012534.pub2
26. Roberge S., Nicolaides K., Demers S., Hyett J., Chaillet N., Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017;216(2):110-120.e6. https://doi.org/10.1016/j.ajog.2016.09.076
27. Filipek A., Jurewicz E. Preeclampsia – a disease of pregnant women. Postepy Biochem. 2018;64(4):232-229. https://doi.org/10.18388/pb.2018_146
28. Levy R. A., de Jesús G. R., de Jesús N. R., Klumb E. M. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmun. Rev. 2016;15(10):955-963. https://doi.org/10.1016/j.autrev.2016.07.014
29. Dağlı Ü., Kalkan İ. H. Treatment of reflux disease during pregnancy and lactation. Turk. J. Gastroenterol. 2017;28(Suppl.1):S53-S56. https://doi.org/10.5152/tjg.2017.14
30. Bandoli G., Palmsten K., Forbess Smith C. J., Chambers C. D. A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes. Rheum. Dis. Clin. North. Am. 2017;43(3):489-502. https://doi.org/10.1016/j.rdc.2017.04.013
31. Palmsten K., Rolland M., Hebert M. F., Clowse M. E. B., Schatz M. [et al.]. Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose. Pharmacoepidemiol. Drug Saf. 2018;27(4):430-438. https://doi.org/10.1002/pds.4410
32. Horta-Baas G. Risk-benefit balance assessment of colchicine use during pregnancy. Med. Clin. (Barc). 2017;148(6):283-285. https://doi.org/10.1016/j.medcli.2016.12.013
33. McNamara N., Ibrahim A., Satti Z., Ibrahim M., Kiernan T. J. Acute pericarditis: a review of current diagnostic and management guidelines. Future Cardiol. 2019;15(2):119-126. https://doi.org/10.2217/fca-2017-0102

Keywords: pericardial lesions, pericarditis, pregnancy, treatment of pericarditis